<unk>  (INN; also called DU-6859a) is a fluoroquinolone antibiotic that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Sankyo Co., which brought ofloxacin and levofloxacin to the market.<unk>  is currently marketed in Japan by Daiichi Sankyo under the tradename Gracevit.
Sitafloxacin
Azithromycin 
Difloxacin
Pefloxacin
Delafloxacin
Gemifloxacin
Telithromycin
Roxithromycin